These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
638 related articles for article (PubMed ID: 34237949)
1. Triazavirin might be the new hope to fight Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Hudecová IMJČGKMPL Ceska Slov Farm; 2021; 70(1):18-25. PubMed ID: 34237949 [TBL] [Abstract][Full Text] [Related]
2. Triazavirin - Potential Inhibitor for 2019-nCoV Coronavirus M Protease: A DFT Study. Shahab S; Sheikhi M Curr Mol Med; 2021; 21(8):645-654. PubMed ID: 32436829 [TBL] [Abstract][Full Text] [Related]
4. Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus. Al-Beltagi S; Preda CA; Goulding LV; James J; Pu J; Skinner P; Jiang Z; Wang BL; Yang J; Banyard AC; Mellits KH; Gershkovich P; Hayes CJ; Nguyen-Van-Tam J; Brown IH; Liu J; Chang KC Viruses; 2021 Feb; 13(2):. PubMed ID: 33546185 [TBL] [Abstract][Full Text] [Related]
5. [Comparison of pathological changes and pathogenic mechanisms caused by H1N1 influenza virus, highly pathogenic H5N1 avian influenza virus, SARS-CoV, MERS-CoV and 2019-nCoV]. Liu M; Feng RE; Li Q; Zhang HK; Wang YG Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):511-516. PubMed ID: 32392945 [TBL] [Abstract][Full Text] [Related]
6. Interaction and antiviral treatment of coinfection between SARS-CoV-2 and influenza in vitro. Liu D; Leung KY; Lam HY; Zhang R; Fan Y; Xie X; Chan KH; Hung IF Virus Res; 2024 Jul; 345():199371. PubMed ID: 38621598 [TBL] [Abstract][Full Text] [Related]
7. Viral interference between severe acute respiratory syndrome coronavirus 2 and influenza A viruses. Gilbert-Girard S; Piret J; Carbonneau J; Hénaut M; Goyette N; Boivin G PLoS Pathog; 2024 Jul; 20(7):e1012017. PubMed ID: 39038029 [TBL] [Abstract][Full Text] [Related]
9. N-chlorotaurine is highly active against respiratory viruses including SARS-CoV-2 (COVID-19) Lackner M; Rössler A; Volland A; Stadtmüller MN; Müllauer B; Banki Z; Ströhle J; Luttick A; Fenner J; Sarg B; Kremser L; Tone P; Stoiber H; von Laer D; Wolff T; Schwarz C; Nagl M Emerg Microbes Infect; 2022 Dec; 11(1):1293-1307. PubMed ID: 35418279 [No Abstract] [Full Text] [Related]
10. Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication. Tripp RA; Martin DE Viruses; 2022 Mar; 14(3):. PubMed ID: 35337018 [TBL] [Abstract][Full Text] [Related]
11. The efficacy of triazavirin (riamilovir)-based treatment for coronavirus disease 2019 (COVID-19) in clinical trials and preliminary practical experiences. Malík I; Kováč G; Hudecova L Ceska Slov Farm; 2022; 71(6):239-244. PubMed ID: 36513517 [TBL] [Abstract][Full Text] [Related]
12. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy. Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631 [TBL] [Abstract][Full Text] [Related]
13. XiaoEr LianHuaQinqGan alleviates viral pneumonia in mice infected by influenza A and respiratory syncytial viruses. Li W; Li T; Zhao C; Song T; Mi Y; Chuangfeng Z; Hou Y; Jia Z Pharm Biol; 2022 Dec; 60(1):2355-2366. PubMed ID: 36444944 [TBL] [Abstract][Full Text] [Related]
14. Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus. Ekanger CT; Zhou F; Bohan D; Lotsberg ML; Ramnefjell M; Hoareau L; Røsland GV; Lu N; Aanerud M; Gärtner F; Salminen PR; Bentsen M; Halvorsen T; Ræder H; Akslen LA; Langeland N; Cox R; Maury W; Stuhr LEB; Lorens JB; Engelsen AST Front Cell Infect Microbiol; 2022; 12():841447. PubMed ID: 35360113 [TBL] [Abstract][Full Text] [Related]
15. 4'-Fluorouridine mitigates lethal infection with pandemic human and highly pathogenic avian influenza viruses. Lieber CM; Aggarwal M; Yoon JJ; Cox RM; Kang HJ; Sourimant J; Toots M; Johnson SK; Jones CA; Sticher ZM; Kolykhalov AA; Saindane MT; Tompkins SM; Planz O; Painter GR; Natchus MG; Sakamoto K; Plemper RK PLoS Pathog; 2023 Apr; 19(4):e1011342. PubMed ID: 37068076 [TBL] [Abstract][Full Text] [Related]
16. Influenza A(H1N1)pdm09 Virus but Not Respiratory Syncytial Virus Interferes with SARS-CoV-2 Replication during Sequential Infections in Human Nasal Epithelial Cells. Fage C; Hénaut M; Carbonneau J; Piret J; Boivin G Viruses; 2022 Feb; 14(2):. PubMed ID: 35215988 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of new β-D-N An YJ; Choi SM; Choi ER; Nam YE; Seo EW; Ahn SB; Jang Y; Kim M; Cho JH Bioorg Med Chem Lett; 2023 Mar; 83():129174. PubMed ID: 36764470 [TBL] [Abstract][Full Text] [Related]
18. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets. Huang Y; Skarlupka AL; Jang H; Blas-Machado U; Holladay N; Hogan RJ; Ross TM J Virol; 2022 Mar; 96(5):e0179121. PubMed ID: 34936487 [TBL] [Abstract][Full Text] [Related]